Rapid detection of SARS-CoV-2 with Cas13
Agrawal, S.; Fanton, A.; Chandrasekaran, S. S.; Prywes, N.; Lukarska, M.; Biering, S. B.; Smock, D. C. J.; Mok, A.; Knott, G. J.; Van, E.; Dugan, E.; Kim, S.; Liu, T. Y.; Harris, E.; Stanley, S. A.; Lareau, L. F.; Doudna, J. A.; Savage, D. F.; Hsu, P. D.
Show abstract
Rapid nucleic acid testing is a critical component of a robust infrastructure for increased disease surveillance. Here, we report a microfluidic platform for point-of-care, CRISPR-based molecular diagnostics. We first developed a nucleic acid test which pairs distinct mechanisms of DNA and RNA amplification optimized for high sensitivity and rapid kinetics, linked to Cas13 detection for specificity. We combined this workflow with an extraction-free sample lysis protocol using shelf-stable reagents that are widely available at low cost, and a multiplexed human gene control for calling negative test results. As a proof-of-concept, we demonstrate sensitivity down to 40 copies/L of SARS-CoV-2 in unextracted saliva within 35 minutes, and validated the test on total RNA extracted from patient nasal swabs with a range of qPCR Ct values from 13-35. To enable sample-to-answer testing, we integrated this diagnostic reaction with a single-use, gravity-driven microfluidic cartridge followed by real-time fluorescent detection in a compact companion instrument. We envision this approach for Diagnostics with Coronavirus Enzymatic Reporting (DISCoVER) will incentivize frequent, fast, and easy testing.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Rapid, Low-Cost Detection of Water Contaminants Using Regulated In Vitro Transcription 90%
- Sequencing by avidity enables high accuracy with low reagent consumption 90%
- Highly accurate barcode and UMI error correction using dual nucleotide dimer blocks allows direct single-cell nanopore transcriptome sequencing 90%
Similar papers in this journal
- Harnessing recombinase polymerase amplification for rapid detection of SARS-CoV-2 in resource-limited settings 95%
- Point-Of-Need One-Pot Multiplexed RT-LAMP Test For Detecting Three Common Respiratory Viruses In Saliva 94%
- Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assay 93%
Similar papers in this journal
- Development and Implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities 95%
- Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery 94%
- SARSeq, a robust and highly multiplexed NGS assay for parallel detection of SARS-CoV2 and other respiratory infections 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.